Gastroenterology
News
Therapies Can Extend Life in Infiltrative Liver Cancer
Major Finding: Transcatheter arterial chemoembolization/ radiofrequency ablation gives patients with infiltrative HCC an extra 3 months of life on...
Case Reports
Posterior reversible encephalopathy syndrome: a potential side effect of gemcitabine
News
Medicare Study Confirms Colonoscopy's Cancer Prevention Power
Major Finding: Colonoscopy was associated with a 73% lower risk of distal colorectal cancer (hazard ratio, 0.27) and a 54% lower risk of proximal...
News
Long-Term Risk of GI Cancers Not Elevated in Celiac Patients
Major Finding: Overall, celiac disease patients do not have a significantly elevated risk of gastrointestinal cancers, nor do patients with celiac...
News
Novel Hep C Treatment Excludes Peginterferon Alfa
Major Finding: A novel regimen that did not include peginterferon alfa resulted in a 100% virologic response rate in patients with hepatitis C...
News
Study Supports HBV Screening, Prophylaxis in Chemotherapy Patients
Major Finding: Among patients whose hepatitis B reactivated during chemotherapy, mortality was much lower for those who had received prophylaxis...
News
Possible Cancer Link to Diabetes Drugs Stirs Controversy
Major Finding: The risk of pancreatic cancer was increased with exenatide and sitagliptin versus control treatments, with respective odds ratios...
News
Study Supports Altering Surveillance for Barrett's Esophagus
Major Finding: The incidence of esophageal adenocarcinoma among all patients in Denmark with Barrett’s esophagus was 1.2 cases per 1,000 person-...
News
AFP Level Predicts Mortality in Hepatitis C-Related Liver Cancer
Major Finding: The 5-year survival rate for hepatocellular carcinoma was low overall at only 12%, but it was extremely low, at 1%, in patients...
News
Laparoscopic Surgery Safe for Radical Rectal Cancer Resection
Major Finding: The circumferential resection margin was 1.3 cm after laparoscopic and open surgery (P = .16).Data Source: A noninferiority...
News
Nix Oxaliplatin, Up Radiation in Locally Advanced Rectal Cancer
Major Finding: At 3 years, there were no significant differences between Cap45 and Capox50 in local recurrence (6.1% vs. 4.4%), distant metastases...